The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation
Objective: To determine whether testing for cytochrome P450 (CYP) polymorphisms in adults entering antipsychotic treatment for schizophrenia leads to improvement in outcomes, is useful in medical, personal or public health decision-making, and is a cost-effective use of health-care resources. Data s...
Main Authors: | N Fleeman, C McLeod, A Bagust, S Beale, A Boland, Y Dundar, A Jorgensen, K Payne, M Pirmohamed, S Pushpakom, T Walley, P de Warren-Penny, R Dickson |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2010-01-01
|
Series: | Health Technology Assessment |
Subjects: | |
Online Access: | https://doi.org/10.3310/hta14030 |
Similar Items
-
Oxidation of Antipsychotics
by: Natalia A. Shnayder, et al.
Published: (2022-05-01) -
Economic Impact of the Application of a Precision Medicine Model (5SPM) on Psychotic Patients
by: Carrascal-Laso L, et al.
Published: (2021-08-01) -
Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment
by: Grace Zdesenko, et al.
Published: (2022-06-01) -
Pharmacogenetics of schizophrenia in real clinical practice: a clinical case
by: R. F. Nasyrova, et al.
Published: (2018-12-01) -
Engineering cytochrome P450s for bioremediation /
by: 242771 Kellner, David G., et al.